Merit Common Stock vs Deferred Long Term Liab Analysis

MMSI Stock

USD 80.83 0.72 0.90%

Merit Medical financial indicator trend analysis is infinitely more than just investigating Merit Medical Systems recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Merit Medical Systems is a good investment. Please check the relationship between Merit Medical Common Stock and its Deferred Long Term Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Common Stock vs Deferred Long Term Liab

Common Stock vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Merit Medical Systems Common Stock account and Deferred Long Term Liab. At this time, the significance of the direction appears to have strong relationship.

The correlation between Merit Medical's Common Stock and Deferred Long Term Liab is 0.77. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Merit Medical Systems, assuming nothing else is changed. The correlation between historical values of Merit Medical's Common Stock and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Merit Medical Systems are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Common Stock i.e., Merit Medical's Common Stock and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.77

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Common Stock

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Merit Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Merit Medical Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

As of now, Merit Medical's Enterprise Value is increasing as compared to previous years.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	406.9M	418.0M	400.3M	420.3M
Cost Of Revenue	589.4M	631.9M	731.1M	767.6M

Total Operating Expenses Cost Of Revenue

Merit Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Cash	Cash And Short Term Investments	Accounts Payable	Non Currrent Assets Other	Common Stock Total Equity	Common Stock
Total Assets		0.9	0.9	0.93	0.98	0.93	0.72	0.96	0.95	0.98	0.69	0.93	0.99	0.85	-0.39	0.97	0.94	0.93	0.56	0.87	0.74	0.74	0.95	0.79	0.98	0.94
Short Long Term Debt Total	0.9		0.66	0.71	0.8	0.75	0.67	0.87	0.77	0.8	0.44	0.99	0.85	0.82	-0.4	0.97	0.82	0.95	0.21	0.68	0.9	0.9	0.78	0.63	0.81	0.72
Other Current Liab	0.9	0.66		0.99	0.95	0.92	0.61	0.85	0.93	0.96	0.74	0.71	0.92	0.7	-0.38	0.8	0.9	0.75	0.7	0.85	0.49	0.49	0.91	0.73	0.95	0.97
Total Current Liabilities	0.93	0.71	0.99		0.98	0.95	0.66	0.9	0.96	0.98	0.78	0.75	0.95	0.76	-0.4	0.84	0.92	0.78	0.73	0.87	0.52	0.52	0.95	0.77	0.97	0.98
Total Stockholder Equity	0.98	0.8	0.95	0.98		0.95	0.66	0.96	0.96	0.99	0.76	0.83	0.99	0.83	-0.34	0.9	0.95	0.87	0.67	0.87	0.64	0.64	0.97	0.8	0.99	0.98
Property Plant And Equipment Net	0.93	0.75	0.92	0.95	0.95		0.78	0.91	0.97	0.96	0.84	0.79	0.93	0.79	-0.36	0.86	0.9	0.76	0.71	0.85	0.5	0.5	0.94	0.71	0.92	0.93
Net Debt	0.72	0.67	0.61	0.66	0.66	0.78		0.62	0.83	0.72	0.7	0.73	0.64	0.5	-0.53	0.75	0.52	0.49	0.59	0.83	0.27	0.27	0.66	0.65	0.62	0.65
Retained Earnings	0.96	0.87	0.85	0.9	0.96	0.91	0.62		0.89	0.94	0.7	0.87	0.98	0.95	-0.33	0.92	0.96	0.93	0.52	0.74	0.75	0.75	0.95	0.75	0.93	0.89
Non Current Assets Total	0.95	0.77	0.93	0.96	0.96	0.97	0.83	0.89		0.98	0.82	0.82	0.93	0.73	-0.42	0.89	0.85	0.76	0.75	0.95	0.5	0.5	0.94	0.83	0.94	0.96
Net Receivables	0.98	0.8	0.96	0.98	0.99	0.96	0.72	0.94	0.98		0.78	0.83	0.98	0.81	-0.39	0.9	0.93	0.84	0.7	0.89	0.6	0.6	0.96	0.81	0.98	0.98
Common Stock Shares Outstanding	0.69	0.44	0.74	0.78	0.76	0.84	0.7	0.7	0.82	0.78		0.5	0.7	0.59	-0.22	0.58	0.64	0.45	0.87	0.74	0.16	0.16	0.78	0.68	0.69	0.75
Non Current Liabilities Total	0.93	0.99	0.71	0.75	0.83	0.79	0.73	0.87	0.82	0.83	0.5		0.87	0.8	-0.4	0.99	0.81	0.93	0.3	0.76	0.85	0.85	0.8	0.69	0.85	0.77
Inventory	0.99	0.85	0.92	0.95	0.99	0.93	0.64	0.98	0.93	0.98	0.7	0.87		0.87	-0.36	0.93	0.96	0.92	0.58	0.83	0.72	0.72	0.97	0.77	0.98	0.95
Other Current Assets	0.85	0.82	0.7	0.76	0.83	0.79	0.5	0.95	0.73	0.81	0.59	0.8	0.87		-0.34	0.82	0.89	0.88	0.34	0.55	0.76	0.76	0.87	0.65	0.79	0.72
Other Stockholder Equity	-0.39	-0.4	-0.38	-0.4	-0.34	-0.36	-0.53	-0.33	-0.42	-0.39	-0.22	-0.4	-0.36	-0.34		-0.42	-0.34	-0.3	-0.19	-0.38	-0.2	-0.2	-0.36	-0.35	-0.34	-0.34
Total Liab	0.97	0.97	0.8	0.84	0.9	0.86	0.75	0.92	0.89	0.9	0.58	0.99	0.93	0.82	-0.42		0.87	0.94	0.4	0.82	0.82	0.82	0.87	0.74	0.91	0.85
Property Plant And Equipment Gross	0.94	0.82	0.9	0.92	0.95	0.9	0.52	0.96	0.85	0.93	0.64	0.81	0.96	0.89	-0.34	0.87		0.92	0.46	0.69	0.75	0.75	0.94	0.62	0.94	0.9
Total Current Assets	0.93	0.95	0.75	0.78	0.87	0.76	0.49	0.93	0.76	0.84	0.45	0.93	0.92	0.88	-0.3	0.94	0.92		0.25	0.65	0.94	0.94	0.84	0.64	0.89	0.8
Short Term Debt	0.56	0.21	0.7	0.73	0.67	0.71	0.59	0.52	0.75	0.7	0.87	0.3	0.58	0.34	-0.19	0.4	0.46	0.25		0.77	-0.09	-0.09	0.65	0.72	0.62	0.73
Intangible Assets	0.87	0.68	0.85	0.87	0.87	0.85	0.83	0.74	0.95	0.89	0.74	0.76	0.83	0.55	-0.38	0.82	0.69	0.65	0.77		0.39	0.39	0.82	0.87	0.87	0.9
Cash	0.74	0.9	0.49	0.52	0.64	0.5	0.27	0.75	0.5	0.6	0.16	0.85	0.72	0.76	-0.2	0.82	0.75	0.94	-0.09	0.39		1.0	0.61	0.43	0.68	0.55
Cash And Short Term Investments	0.74	0.9	0.49	0.52	0.64	0.5	0.27	0.75	0.5	0.6	0.16	0.85	0.72	0.76	-0.2	0.82	0.75	0.94	-0.09	0.39	1.0		0.61	0.43	0.68	0.55
Accounts Payable	0.95	0.78	0.91	0.95	0.97	0.94	0.66	0.95	0.94	0.96	0.78	0.8	0.97	0.87	-0.36	0.87	0.94	0.84	0.65	0.82	0.61	0.61		0.77	0.95	0.94
Non Currrent Assets Other	0.79	0.63	0.73	0.77	0.8	0.71	0.65	0.75	0.83	0.81	0.68	0.69	0.77	0.65	-0.35	0.74	0.62	0.64	0.72	0.87	0.43	0.43	0.77		0.77	0.79
Common Stock Total Equity	0.98	0.81	0.95	0.97	0.99	0.92	0.62	0.93	0.94	0.98	0.69	0.85	0.98	0.79	-0.34	0.91	0.94	0.89	0.62	0.87	0.68	0.68	0.95	0.77		0.99
Common Stock	0.94	0.72	0.97	0.98	0.98	0.93	0.65	0.89	0.96	0.98	0.75	0.77	0.95	0.72	-0.34	0.85	0.9	0.8	0.73	0.9	0.55	0.55	0.94	0.79	0.99

Click cells to compare fundamentals

Merit Medical Account Relationship Matchups

Merit Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.8B	1.7B	1.6B	1.7B	2.3B	2.4B
Short Long Term Debt Total	523.7M	435.1M	315.0M	268.8M	891.4M	935.9M
Other Current Liab	108.0M	114.8M	161.6M	129.9M	120.4M	126.5M
Total Current Liabilities	181.7M	185.0M	236.3M	220.6M	203.6M	213.7M
Total Stockholder Equity	949.9M	958.6M	1.0B	1.1B	1.2B	1.3B
Property Plant And Equipment Net	459.0M	461.0M	437.6M	448.2M	446.6M	468.9M
Net Debt	479.4M	378.2M	247.3M	210.3M	302.2M	317.3M
Retained Earnings	368.2M	357.8M	406.3M	480.8M	575.2M	603.9M
Non Current Assets Total	1.3B	1.2B	1.2B	1.1B	1.2B	1.3B
Net Receivables	168.5M	158.0M	172.8M	178.4M	189.3M	198.7M
Common Stock Shares Outstanding	56.2M	55.4M	57.4M	57.7M	58.4M	39.5M
Liabilities And Stockholders Equity	1.8B	1.7B	1.6B	1.7B	2.3B	2.4B
Non Current Liabilities Total	625.7M	520.8M	372.2M	298.9M	919.7M	965.7M
Inventory	225.7M	198.0M	221.9M	266.0M	303.9M	319.1M
Other Current Assets	12.5M	13.1M	16.1M	22.3M	26.2M	27.5M
Other Stockholder Equity	(294K)	(5.5M)	(8.0M)	(11.6M)	(10.4M)	(9.9M)
Total Liab	807.4M	705.8M	608.5M	519.6M	1.1B	1.2B
Property Plant And Equipment Gross	459.0M	461.0M	652.3M	686.2M	775.6M	814.4M
Total Current Assets	454.5M	429.7M	482.2M	529.1M	1.1B	1.2B
Accumulated Other Comprehensive Income	(5.3M)	(5.5M)	(8.0M)	(11.6M)	(11.3M)	(10.8M)
Short Term Debt	19.1M	20.4M	19.1M	22.3M	12.1M	9.2M
Intangible Assets	445.3M	367.9M	319.3M	275.9M	325.9M	342.2M
Cash	44.3M	56.9M	67.8M	58.4M	589.1M	618.6M
Cash And Short Term Investments	44.3M	56.9M	67.8M	58.4M	589.1M	618.6M
Accounts Payable	54.6M	49.8M	55.6M	68.5M	65.9M	69.2M
Non Currrent Assets Other	24.3M	25.6M	26.7M	28.8M	32.3M	33.9M
Common Stock Total Equity	587.0M	606.2M	641.5M	675.2M	776.5M	815.3M
Common Stock	587.0M	606.2M	641.5M	675.2M	638.2M	670.1M
Other Liab	120.7M	102.7M	76.3M	52.4M	60.3M	35.4M
Other Assets	28.1M	227.7M	47.5M	31.9M	36.7M	25.7M
Long Term Debt	432.0M	343.7M	234.4M	186.8M	823.0M	864.2M
Good Will	353.2M	363.5M	361.7M	359.8M	382.2M	401.4M
Property Plant Equipment	459.0M	382.7M	437.6M	383.0M	440.4M	462.4M
Net Tangible Assets	151.4M	227.1M	358.8M	508.7M	585.0M	614.3M
Long Term Debt Total	432.0M	343.7M	234.4M	186.8M	214.8M	281.4M
Long Term Investments	17.1M	12.0M	14.7M	15.6M	19.1M	12.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:

How To Invest In Merit

Details

Is Merit Stock a good investment?

Details

What is Merit Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Merit Stock analysis

When running Merit Medical's price analysis, check to measure Merit Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merit Medical is operating at the current time. Most of Merit Medical's value examination focuses on studying past and present price action to predict the probability of Merit Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merit Medical's price. Additionally, you may evaluate how the addition of Merit Medical to your portfolios can decrease your overall portfolio volatility.

	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes

Is Merit Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.333

Earnings Share

1.74

Revenue Per Share

22.224

Quarterly Revenue Growth

0.087

Return On Assets

0.0425

The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Merit Common Stock vs Deferred Long Term Liab Analysis

Common Stock vs Deferred Long Term Liab

Common Stock vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Common Stock

Deferred Long Term Liab

Merit Medical fundamental ratios Correlations

Merit Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Merit Medical fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Merit Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Inventory	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Current Liabilities	+ 0.99	Other Current Liab
Net Receivables	+ 0.99	Total Stockholder Equity
Inventory	+ 0.99	Total Stockholder Equity

Other Stockholder Equity	- 0.53	Net Debt
Total Liab	- 0.42	Other Stockholder Equity
Other Stockholder Equity	- 0.42	Non Current Assets Total
Other Stockholder Equity	- 0.4	Non Current Liabilities Total
Other Stockholder Equity	- 0.4	Total Current Liabilities
Other Stockholder Equity	- 0.4	Short Long Term Debt Total